Evaluation of the Safety and Efficacy of NBL-015 in Patients With Advanced Solid Tumors
Clinical trial NCT05153096 · UNKNOWN
Trial details
- NCT number
- NCT05153096
- Sponsor
- NovaRock Biotherapeutics, Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-01
- Primary completion
- 2025-12-01
- Enrollment
- 410
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.